Drug Trial Radar · NCT06309953
A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Last checked: Nov 20, 2026Latest source record: Oct 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99
Actual
Start
Feb 28, 2024
Primary completion
Jun 17, 2024
Study completion Jun 17, 2024
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Mar 13, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
An Open-Label, Multicenter, Phase 4 Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Conditions
- Dry Eye
Interventions
MieboDrug
Miebo® (perfluorohexyloctane ophthalmic solution) Dosage: one drop of MIEBO four times daily into each eye Dosage form: Ophthalmic solution: 100% perfluorohexyloctane. Frequency: 4 times daily for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline (CFB) in Dry Eye Symptom Severity at Visit 3Time frame: Change from baseline in VAS at Visit 3 (Day 7 ± 1 day)
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Site 207
Birmingham, Alabama
Site 205
Petaluma, California
Site 203
Pittsburg, Kansas
Site 204
Stillwater, Minnesota
Site 202
Kansas City, Missouri
Site 201
Brecksville, Ohio
Site 206
Westlake, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.